Worth reading
55In focus
Scored from 2 of 5 sectionsDirection
Deterioration
Direction inferred from the company’s description.Scale
1761300
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Monthly exercise status of stock acquisition rights with an exercise price adjustment clause
発行・処分する株式数1,761,300Shares
Number of shares delivered during the month: 1,761,300 shares (all newly issued shares)
発行済株式総数
Exercise ratio relating to exercise restrictions: 2.59% (monthly number of shares delivered for all series combined / number of listed shares as of the payment date for the issuance)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Exercise price in March 2026: ¥93.9–¥105.8. Details and floor of the adjustment clause: Not disclosed
Number of Stock Acquisition Rights
Total number issued: 135,997 (17,613 represented 12.95% of the total number issued); unexercised balance as of the end of the month preceding the month covered: 107,738; unexercised balance as of the end of the month covered: 90,125
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with exercise restrictions pursuant to Article 434 of the Tokyo Stock Exchange Rules on Listing of Securities and the Japan Securities Dealers Association Rules Concerning the Handling of Third-Party Allotments.
Most recent equity financing
15 December 2025: Issuance of the 23rd Series of Stock Acquisition Rights (with Exercise Price Adjustment Clause). Amount: Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly exercise status of stock acquisition rights with an exercise price adjustment clause |
| Number of shares to be issued or disposed of | Number of shares delivered during the month: 1,761,300 shares (all newly issued shares) |
| Dilution Rate | Exercise ratio relating to exercise restrictions: 2.59% (monthly number of shares delivered for all series combined / number of listed shares as of the payment date for the issuance) |
| Exercise price | Exercise price in March 2026: ¥93.9–¥105.8. Details and floor of the adjustment clause: Not disclosed |
| Number of Stock Acquisition Rights | Total number issued: 135,997 (17,613 represented 12.95% of the total number issued); unexercised balance as of the end of the month preceding the month covered: 107,738; unexercised balance as of the end of the month covered: 90,125 |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with exercise restrictions pursuant to Article 434 of the Tokyo Stock Exchange Rules on Listing of Securities and the Japan Securities Dealers Association Rules Concerning the Handling of Third-Party Allotments. |
| Most recent equity financing | 15 December 2025: Issuance of the 23rd Series of Stock Acquisition Rights (with Exercise Price Adjustment Clause). Amount: Not disclosed |
Items this document does not state (21)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyTotal number of issued sharesBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status in March 2026 of the 23rd Series of Stock Acquisition Rights issued on 15 December 2025.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.